OPTILITE Trademark

Trademark Overview


On Tuesday, October 17, 2017, a trademark application was filed for OPTILITE with the United States Patent and Trademark Office. The USPTO has given the OPTILITE trademark a serial number of 87648610. The federal status of this trademark filing is REGISTERED as of Tuesday, May 22, 2018. This trademark is owned by The Binding Site Group Limited. The OPTILITE trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic reagents for medicinal use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, multiple myeloma, light chain deposition disease, kidney disorders, plasma cell disorders, and immune deficiencies; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Reagents and media for medical and veterinary diagnostic purposes; Veterinary diagnostic reagents
optilite

General Information


Serial Number87648610
Word MarkOPTILITE
Filing DateTuesday, October 17, 2017
Status700 - REGISTERED
Status DateTuesday, May 22, 2018
Registration Number5474976
Registration DateTuesday, May 22, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements


Certificate of Correction for RegistrationIn the statement, line 1, "The Binding Site, Ltd." should be deleted, and The Binding Site Group Limited should be inserted.
Goods and ServicesDiagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic reagents for medicinal use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, multiple myeloma, light chain deposition disease, kidney disorders, plasma cell disorders, and immune deficiencies; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Reagents and media for medical and veterinary diagnostic purposes; Veterinary diagnostic reagents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 26, 2017
Primary Code005
First Use Anywhere DateMonday, January 26, 2015
First Use In Commerce DateMonday, March 9, 2015

Trademark Owner History


Party NameThe Binding Site Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBirmingham B151QT
GB

Party NameThe Binding Site Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBirmingham B151QT
GB

Party NameThe Binding Site Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBirmingham B151QT
GB

Trademark Events


Event DateEvent Description
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, October 20, 2017NEW APPLICATION ENTERED
Thursday, October 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 25, 2018ASSIGNED TO EXAMINER
Thursday, January 25, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 22, 2018REGISTERED-PRINCIPAL REGISTER
Friday, February 4, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 4, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 4, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 4, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 4, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 4, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, August 26, 2022TEAS SECTION 7 REQUEST RECEIVED
Saturday, January 21, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, January 21, 2023CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, February 28, 2023NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Tuesday, March 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 22, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 26, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, March 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 22, 2024TEAS SECTION 8 & 15 RECEIVED